Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TI4U
|
|||
| Former ID |
DNCL002311
|
|||
| Drug Name |
EGFR/IGFR tandem adnectin
|
|||
| Synonyms |
BMS-964210
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Preclinical | [1] | |
| Company |
Bristol-Myers Squibb
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026610) | |||
| REF 2 | Clinical pipeline report, company report or official report of Bristol-Myers Squibb. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.